Medical Consumables & Disposables Consulting
Turning operational resilience and product innovation into sustainable growth for medical consumables businesses.
Partners
Who Trust Us
Driving Transformation across the Medical Consumables Value Chain
Medical disposables and consumables are no longer competing on cost alone. Growth increasingly relies on operational resilience, product differentiation, and alignment with emerging care delivery models. Market players need to strengthen their pricing power with value-added portfolios, expand into emerging care settings, and streamline clinical workflows with digital capabilities. But above all, the rising regulatory and sustainability expectations must be met as new regulations like the EU’s PPWR add 4-6 months of compliance lead time.
Backed by deep medtech consulting expertise, Stellarix helps organizations strengthen portfolio strategies, secure margins, identify innovation and diversification opportunities, and build long-term competitiveness with actionable technology and market intelligence.
Infection Prevention
Green Materials Adoption
Hospital-to-Home
Smart Consumables Integration
Supply Chain Resilience
Core Focus Areas
Unlocking growth across the MedTech consumables value chain.
Infection Prevention & Wound Care
The global diabetic population is estimated to cross 550 million by 2030, increasing the demand for advanced wound care, surgical dressings, infection control, and sterilization solutions. At Stellarix, we help clients differentiate their portfolios, navigate regulatory mandates, and drive innovation for long-term growth.
Infusion, Drug Delivery & Vascular Access
The shift to home-based care and emerging product expectations are reshaping vascular and infusion access markets. We help organizations strengthen their product portfolios, navigate regulatory mandates, and accelerate market differentiation strategies for emerging care settings.
Patient Care & Therapeutic Consumables
The growing burden of chronic diseases is driving sustained demand for therapeutic consumables across acute and chronic care. We help organizations prioritize high-value therapeutic segments, capture recurring revenue opportunities, and optimize portfolio investments.
Surgical & Interventional Consumables
Rising adoption of robotic-assisted and minimally invasive procedures is accelerating demand for specialized surgical consumables. We assist clients in expanding into high-growth segments, optimizing product portfolios, and identifying next-gen surgical technology opportunities.
Diagnostic & Laboratory Consumables
Stricter quality requirements and growing volume of diagnostic tests are increasing demand for reliable laboratory consumables. We help suppliers strengthen regulatory readiness, develop differentiated products, and improve quality for long-term market success.
Need Strategic Guidance for Your Business ?
Strategic Hurdles in Consumables & Disposables
Consumable & disposable businesses face structural pressures that directly impact profitability, differentiation, and operational stability.
Intense Pricing Pressure
In 2025, medical supply producer prices increased by 4.1% while hospital operating margins remained at 1.6%. This Increased discount demands from hospitals and raised inventory & supply chain costs, forcing leaders to improve pricing strategies, demonstrate clinical value, and improve cost structures.
Shifting Growth Across Consumables Markets
There is a considerable gap between core surgical volumes and chronic disease prevalence. Growth constrains as the category matures, shifting investment towards high-value segments like robotic surgery and wound care consumables. These segments are currently expanding at 3.5x the category average.
Dependence on Cost & Supply Efficiency
With rising medical-grade resin and polymer costs and HHS reporting 15+ raw material supply alerts, supply chain resilience and cost optimization become critical for minimizing disruptions and volatility.
Commoditization of Products
FDA cleared 3,600+ 510(k) submissions in 2025, increasing new market entries by 100% since 2020. However, limited differentiation continues to restrict pricing power, making value engineering and sustainable growth challenging.
High Competition & Low Negotiation Power
Over 90% of U.S. hospital purchasing decisions are driven by the top five GPOs. They are increasing both pricing pressures and demanding that suppliers compete through cost positioning and insight-led negotiation strategies.
Sustainability & Compliance Complexities
Commercialization costs are constantly rising with increasing compliance expectations. Growing MDR recertification costs and average review timelines for Class IIb devices extending to 18 months are further complicating the situation for manufacturers. They are now looking for ways to embed sustainability and regulatory readiness into market and product strategies.
How We Drive Client Impact
Helping organizations make better strategic decisions with greater conviction.
Stellarix combines technology intelligence, innovation strategy, and IP advisory services. We guide where organizations invest, scale, and build defensible advantage through expert technology benchmarking and opportunity mapping.
Our strategic and technology intelligence has assisted clients prioritize their investments, validate technical viability, strengthen their IP positions, and scale with confidence. They uncover high-potential opportunities, anticipate competitive shifts and weak growth signals, and build innovation portfolios to turn technology choices into measurable growth.
Market intelligence, customer insights, and strategic alliances advisory that enable organizations to uncover new revenue streams, validate growth opportunities, and build partnerships before markets turn mainstream.
Sustainability ecosystem intelligence, strategy, and circular economy advisory to assist industry players in prioritizing high-impact initiatives and turning ESG commitments into tangible, lasting value.
Value and cost intelligence, operational risk & supply chain risk assessment that help companies identify hidden margin leaks and protect continuity amid rising costs and supply pressures.
Risk intelligence, regulatory advisory, and scenario planning to enable industry players to separate which disruptions matter most and build resilience across multiple possible futures.
Concept evaluation and go-to-market strategy advisory for supporting the organization in validating market readiness and accelerating commercialization from launch to scale.
Our custom dashboards turn complex data into actionable insights with advanced filters and drill-down features to track trends, competitors, performance, and opportunities in real time.
Explore more in the MedTech Industry
Discover how precision diagnostics, connected care, and next-generation medical technologies are reshaping healthcare infrastructure, clinical adoption, and competitive positioning.
Outcomes That Speak for Themselves
A leading diagnostics company sought to expand into the at-home testing segment, targeting aging populations…
A market leader in surgical robots engaged Stellarix to enhance its orthopaedic portfolio and value…
The ophthalmic medical device industry is evolving rapidly, driven by digital transformation and sustainability goals.…